Skip to content
HORMONES (Archive)
  • HOME
  • ARCHIVE
    • VOLUME 16 (2017)
    • VOLUME 15 (2016)
    • VOLUME 14 (2015)
    • VOLUME 13 (2014)
    • VOLUME 12 (2013)
    • VOLUME 11 (2012)
    • VOLUME 10 (2011)
    • VOLUME 9 (2010)
    • VOLUME 8 (2009)
    • VOLUME 7 (2008)
    • VOLUME 6 (2007)
      • Issue 1 (January-March)61
      • Issue 2 (April-June)62
    • VOLUME 5 (2006)
      • Issue 1 (January-March)51
      • Issue 2 (April-June)52
    • VOLUME 4 (2005)
      • Issue 1 (January-March)41
      • Issue 2 (April-June)42
    • VOLUME 3 (2004)
    • VOLUME 2 (2003)
    • VOLUME 1 (2002)
      • Issue 1 (January-March)
      • Issue 2 (April-June)12
      • Issue 3 (July-September)13
      • Issue 4 (October- December)14
  • SEARCH
  • CONTACT US

Tag: Familial hypercholesterolemia

Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

Posted on by

Read More

Posted in Issue 1 (January- March), Journal Articles, Volume 15 (2016) Tagged cardiovascular disease, diabetes, Ezetimibe, Familial hypercholesterolemia, High-risk, LDL cholesterol, PCSK9, Statin intolerance, Statins Leave a comment

An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)

Posted on by

Read More

Posted in Issue 3 (July-September), Journal Articles, Volume 16 (2017) Tagged Familial hypercholesterolemia, Greece, Hellenic Familial Hypercholesterolemia Registry, Registry Leave a comment
Theme by Out the Box